+

WO2008108285A1 - ペプチド - Google Patents

ペプチド Download PDF

Info

Publication number
WO2008108285A1
WO2008108285A1 PCT/JP2008/053596 JP2008053596W WO2008108285A1 WO 2008108285 A1 WO2008108285 A1 WO 2008108285A1 JP 2008053596 W JP2008053596 W JP 2008053596W WO 2008108285 A1 WO2008108285 A1 WO 2008108285A1
Authority
WO
WIPO (PCT)
Prior art keywords
preventing
hepatic function
function disorder
peptide
activity
Prior art date
Application number
PCT/JP2008/053596
Other languages
English (en)
French (fr)
Inventor
Hiroshi Kawakami
Yukio Kadooka
Tomohiro Hosoya
Kenji Sato
Original Assignee
Snow Brand Milk Products Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39738168&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2008108285(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Snow Brand Milk Products Co., Ltd. filed Critical Snow Brand Milk Products Co., Ltd.
Priority to ES08721044T priority Critical patent/ES2423705T3/es
Priority to EP08721044.9A priority patent/EP2123666B1/en
Priority to CN2008800069847A priority patent/CN101636408B/zh
Publication of WO2008108285A1 publication Critical patent/WO2008108285A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/261—Animal proteins
    • A21D2/263—Animal proteins from dairy products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)

Abstract

　チーズに含まれる、式(1)～(28)で表されるアミノ酸配列からなるペプチドを有効成分とする肝機能障害抑制剤、あるいは肝機能障害抑制用飲食品又は飼料。これらのペプチドは、肝細胞傷害抑制作用があり、しかも低用量で肝機能障害の抑制効果を有し、しかも、日常的な摂取が可能である。
PCT/JP2008/053596 2007-03-02 2008-02-29 ペプチド WO2008108285A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES08721044T ES2423705T3 (es) 2007-03-02 2008-02-29 Péptidos de caseína para su uso como agentes en patologías hepáticas
EP08721044.9A EP2123666B1 (en) 2007-03-02 2008-02-29 Peptides from casein for use as agents in liver pathologies
CN2008800069847A CN101636408B (zh) 2007-03-02 2008-02-29 肽

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-052520 2007-03-02
JP2007052520A JP5188731B2 (ja) 2007-03-02 2007-03-02 ペプチド

Publications (1)

Publication Number Publication Date
WO2008108285A1 true WO2008108285A1 (ja) 2008-09-12

Family

ID=39738168

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/053596 WO2008108285A1 (ja) 2007-03-02 2008-02-29 ペプチド

Country Status (6)

Country Link
EP (1) EP2123666B1 (ja)
JP (1) JP5188731B2 (ja)
KR (1) KR20090126258A (ja)
CN (1) CN101636408B (ja)
ES (1) ES2423705T3 (ja)
WO (1) WO2008108285A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106554387A (zh) * 2015-09-25 2017-04-05 中国科学院大连化学物理研究所 具有ace和dpp-iv双重抑制活性的九肽及其应用
WO2020186155A3 (en) * 2019-03-14 2020-10-22 Lactocore, Inc. Synthetic neuromodulatory peptides

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2151451A4 (en) * 2007-03-23 2010-06-02 Nisshin Pharma Inc COMPOSITION FOR PREVENTION BZW. TREATMENT OF LUNG DISEASES
RU2501808C1 (ru) * 2009-12-28 2013-12-20 Калпис Ко., Лтд. Композиция для улучшения функции мозга и способ улучшения функции мозга
JP5804542B2 (ja) * 2010-03-25 2015-11-04 雪印メグミルク株式会社 脂肪肝予防及び／又は抑制剤
CN113493491B (zh) * 2020-04-08 2023-07-04 清华大学 一种用于预防或治疗溃疡性结肠炎的多肽
CN112587439B (zh) * 2020-12-16 2022-11-15 中科南京绿色制造产业创新研究院 一种抗氧化肽组合物及其制备方法和应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003144090A (ja) 2001-11-13 2003-05-20 Meiji Milk Prod Co Ltd コレステロール代謝改善作用を有するチーズ及び該チーズ添加食品
JP2003300890A (ja) 2002-04-08 2003-10-21 Snow Brand Milk Prod Co Ltd 血中トリグリセリド濃度低下剤
JP2004352958A (ja) 2003-05-30 2004-12-16 Snow Brand Milk Prod Co Ltd 抗酸化剤
WO2005081628A2 (en) * 2004-03-01 2005-09-09 Peptera Pharmaceutical Ltd. Casein derived peptides and therapeutic uses thereof
US20050281914A1 (en) * 2003-06-20 2005-12-22 Steele James L Methods and compositions involving endopeptidases PepO2 and PepO3
JP2007254449A (ja) * 2006-02-22 2007-10-04 Snow Brand Milk Prod Co Ltd 脂質改善剤
JP2007254448A (ja) * 2006-02-24 2007-10-04 Snow Brand Milk Prod Co Ltd ペプチド

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002257814A (ja) * 2001-03-01 2002-09-11 Kirin Brewery Co Ltd 吸収抑制剤
US20070269437A1 (en) * 2003-09-19 2007-11-22 Leukotech A/S Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp)
JP4899147B2 (ja) * 2004-10-08 2012-03-21 雪印メグミルク株式会社 ペプチド
FI20060200A0 (fi) * 2005-04-20 2006-02-27 Glykos Finland Oy Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi
KR20090009862A (ko) * 2006-04-28 2009-01-23 유키지루시 뉴교 가부시키가이샤 펩티드

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003144090A (ja) 2001-11-13 2003-05-20 Meiji Milk Prod Co Ltd コレステロール代謝改善作用を有するチーズ及び該チーズ添加食品
JP2003300890A (ja) 2002-04-08 2003-10-21 Snow Brand Milk Prod Co Ltd 血中トリグリセリド濃度低下剤
JP2004352958A (ja) 2003-05-30 2004-12-16 Snow Brand Milk Prod Co Ltd 抗酸化剤
US20050281914A1 (en) * 2003-06-20 2005-12-22 Steele James L Methods and compositions involving endopeptidases PepO2 and PepO3
WO2005081628A2 (en) * 2004-03-01 2005-09-09 Peptera Pharmaceutical Ltd. Casein derived peptides and therapeutic uses thereof
JP2007254449A (ja) * 2006-02-22 2007-10-04 Snow Brand Milk Prod Co Ltd 脂質改善剤
JP2007254448A (ja) * 2006-02-24 2007-10-04 Snow Brand Milk Prod Co Ltd ペプチド

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HIDEKAZU TONOUCHI ET AL.: "Concanavalin A Yuhatsu Kanshogai Model Mouse ni Okeru Kakushu Cheese no Koka", THE JAPANESE SOCIETY OF NUTRITION AND FOOD SCIENCE TAIKAI KOEN YOSHISHU, vol. 60 th, 2006, pages 267, 3B - 13p *
LAB. ANIM. SCI., vol. 39, 1989, pages 618 - 620
LEMIEUX, L ET AL.: "Application of reversed-phase high-performance liquid chromoatography to the separation of peptides from phosphorylated and dephosphorylated casein hydrolyzates", JOURNAL OF CHROMATOGRAPHY, vol. 473, no. 1, 1989, pages 189 - 206, XP026484598 *
SAITO, T. ET AL.: "Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese.", JOURNAL OF DAIRY SCIENCE, vol. 83, no. 7, 2000, pages 1434 - 1440, XP002942635 *
See also references of EP2123666A4

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106554387A (zh) * 2015-09-25 2017-04-05 中国科学院大连化学物理研究所 具有ace和dpp-iv双重抑制活性的九肽及其应用
CN106554387B (zh) * 2015-09-25 2020-01-21 中国科学院大连化学物理研究所 具有ace和dpp-iv双重抑制活性的九肽及其应用
WO2020186155A3 (en) * 2019-03-14 2020-10-22 Lactocore, Inc. Synthetic neuromodulatory peptides
CN113573723A (zh) * 2019-03-14 2021-10-29 拉托科公司 合成的神经调节肽
EP3938375A4 (en) * 2019-03-14 2022-12-21 Lactocore, Inc. SYNTHETIC NEUROMODULATOR PEPTIDES
US12178838B2 (en) 2019-03-14 2024-12-31 Lactocore, Inc. Synthetic neuromodulatory peptides
AU2020239245B2 (en) * 2019-03-14 2025-03-27 Lactocore, Inc. Synthetic neuromodulatory peptides

Also Published As

Publication number Publication date
EP2123666A4 (en) 2011-01-05
JP5188731B2 (ja) 2013-04-24
EP2123666B1 (en) 2013-05-01
CN101636408B (zh) 2013-12-11
ES2423705T3 (es) 2013-09-23
JP2008214242A (ja) 2008-09-18
EP2123666A1 (en) 2009-11-25
CN101636408A (zh) 2010-01-27
KR20090126258A (ko) 2009-12-08

Similar Documents

Publication Publication Date Title
WO2008108285A1 (ja) ペプチド
WO2008153945A3 (en) Nutraceutical co-crystal compositions
WO2009001786A1 (ja) 生理活性物質含有組成物
EP2045253A4 (en) alpha-amino acid derivative and pharmaceutical agent containing it as an active ingredient
WO2007014124A3 (en) High drug load formulations and dosage forms
WO2007124465A3 (en) Stable emulsion formulations
WO2006127069A3 (en) A delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
WO2006127070A3 (en) An edible composition including a delivery system for active components
WO2007072992A3 (en) Solid preparation containing an insulin sensitizer
MY148723A (en) Use of pinolenic acid for the treatment of obesity
WO2008128775A3 (en) Stabilised pharmaceutical composition containing pregabaline
WO2008003050A3 (en) Gallium nitrate formulations
WO2009135593A3 (de) Feste arzneimittelformulierung mit verzögerter freisetzung
GB2443793B (en) Product, method of manufacture and use
WO2010041832A3 (ko) 패 유래 화합물 함유 항산화 활성 조성물
WO2009038095A1 (ja) セサミン類とビタミンｂ１類とを配合した組成物
WO2011043631A3 (ko) 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물
WO2009068708A8 (es) Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo
WO2007084212A3 (en) Biologically active composition comprising ethylcellulose
WO2006012213A3 (en) Composition and method for delivery of phytochemicals
EP1806134A4 (en) AGENT AND FOOD FOR PREVENTING / ENHANCING FUNCTIONAL DIGESTIVE DISORDER
WO2007079391A3 (en) Drug delivery system for bioadhesion to a vulvovaginal surface
WO2004112511A3 (en) Supplement for restoring growth hormone levels
WO2007099409A3 (en) Therapeutic compositions containing trimethoprim and cranberry extract and methods for treating and preventing urinary tract infections
WO2008041116A3 (en) Formulations of active principles incorporated in slns suitable for transdermal administration

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880006984.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08721044

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008721044

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020097018918

Country of ref document: KR

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载